Posted on 11/5/20
Albireo Reports Q3 2020 Financial Results and Provides Business Update
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today provided a . . .
Posted on 11/5/20
Dyne Therapeutics Reports Third Quarter 2020 Financial Results
WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living . . .
Posted on 11/5/20
Vericel Reports Record Third Quarter Revenues and Net Income
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today . . .
Posted on 11/5/20
Selecta Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
WATERTOWN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR platform to develop tolerogenic therapies . . .
Posted on 11/5/20
Harvard Bioscience Announces Third Quarter 2020 Financial Results
HOLLISTON, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced financial results for the three and nine months ended September 30, . . .
Posted on 11/5/20
Cyclerion Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Updates
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing innovative medicines for people with serious diseases of . . .
Posted on 11/5/20
Arvinas Reports Third Quarter 2020 Financial Results and Provides Corporate Update
NEW HAVEN, Conn., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biopharmaceutical company creating a new class of drugs based on targeted . . .
Posted on 11/5/20
Kymera Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update
WATERTOWN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein . . .
Posted on 11/5/20
Solid Biosciences Reports Third Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy . . .
Posted on 11/5/20
Here's What's Behind Bristol Myers Squibb's Huge Acquisitions
The pharmaceutical industry is famous for generating enormous profits with help from patent-protected exclusivity, but those protections don't last forever. In order to produce steadily growing . . .
Posted on 11/5/20
3 Big Advantages Novavax Has Over Moderna
Moderna (NASDAQ:MRNA) just might win FDA emergency use authorization for its COVID-19 vaccine candidate mRNA-1273 by the end of the year. Only one other coronavirus vaccine . . .
Posted on 11/5/20
Stealth BioTherapeutics Announces Development Financing
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced . . .
Posted on 11/4/20
Atea Pharmaceuticals Closes of IPO
BOSTON, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR), a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapeutics to improve . . .
Posted on 11/3/20
Resonetics Acquires Medical Business of Hutchinson Technology
Resonetics announced today that it has acquired the medical business of Hutchinson Technology, Inc. The HTI Medical business, based in Hutchinson, Minnesota, has developed a number of . . .
Posted on 11/3/20
4 Reasons CVS Health Is a Promising Value Pick
The year 2020 may have been one of Wall Street's craziest. Many technology stocks saw a dramatic increase in share prices, and many mature companies reported . . .
Posted on 11/2/20
Syndax Pharmaceuticals Provides Clinical and Business Update
Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today reported its financial results for the third quarter ended September . . .
Posted on 11/2/20
Scholar Rock Closes Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock Holding Corporation (Nasdaq: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a . . .
Posted on 11/2/20
VBI Vaccines Announces Third Quarter 2020 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today reported financial results for the third . . .
Posted on 11/2/20
Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results
BOSTON, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare . . .
Posted on 11/2/20
Kaleido Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update
LEXINGTON, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO) today announced financial results for the third quarter 2020 and provided a corporate . . .
Posted on 11/2/20
Minerva Neurosciences Reports Third Quarter 2020 Financial Results And Business Updates
WALTHAM, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central . . .
Posted on 11/2/20
Forget Moderna -- This Is A More Lucrative Coronavirus Stock
Moderna (NASDAQ:MRNA) is without a doubt one of the most talked about coronavirus stocks these days. The company was the first to launch its coronavirus vaccine . . .
Posted on 11/2/20
3 Reasons Vertex Is Still a Buy After Its Recent Pipeline Setback
Vertex Pharmaceuticals (NASDAQ:VRTX) reported its third-quarter results after the market closed on Thursday. Based on the stock's subsequent movement, you'd probably think the company announced a . . .
Posted on 11/2/20
3 Reasons to Buy Vertex Pharmaceuticals and 1 Reason Not To
Vertex Pharmaceuticals (NASDAQ:VRTX) is a pharmaceutical company that has utilized its portfolio of medicines for cystic fibrosis (CF) to grow consistently, expanding its trailing revenues by . . .
Posted on 11/1/20
Dan MacDonald PT Joins Peak Physical Therapy & Sports Performance’s Pembroke Clinic
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive
Boston
